| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the management of coagulopathy in acute promyelocytic leukemia
|
Sanz, Miguel A.
|
|
|
191 |
S1 |
p. S63-S67
|
artikel
|
| 2 |
An overview of thrombotic complications of old and new anticancer drugs
|
Levi, Marcel
|
|
|
191 |
S1 |
p. S17-S21
|
artikel
|
| 3 |
Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia
|
Leader, Avi
|
|
|
191 |
S1 |
p. S68-S73
|
artikel
|
| 4 |
Assessing the risk of venous thromboembolism in multiple myeloma
|
Sanfilippo, Kristen M.
|
|
|
191 |
S1 |
p. S74-S78
|
artikel
|
| 5 |
Author index
|
|
|
|
191 |
S1 |
p. S133
|
artikel
|
| 6 |
Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study
|
Ilich, Anton
|
|
|
191 |
S1 |
p. S31-S36
|
artikel
|
| 7 |
Cancer animal models in thrombosis research
|
Palacios-Acedo, Ana-Luisa
|
|
|
191 |
S1 |
p. S112-S116
|
artikel
|
| 8 |
Cancer-associated thrombosis in pediatric patients
|
Barg, Assaf Arie
|
|
|
191 |
S1 |
p. S22-S25
|
artikel
|
| 9 |
Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis
|
Lyman, Gary H.
|
|
|
191 |
S1 |
p. S79-S84
|
artikel
|
| 10 |
Coagulation signaling and cancer immunotherapy
|
Ruf, Wolfram
|
|
|
191 |
S1 |
p. S106-S111
|
artikel
|
| 11 |
Genes and proteins associated with the risk for cancer-associated thrombosis
|
Buijs, Jeroen T.
|
|
|
191 |
S1 |
p. S43-S49
|
artikel
|
| 12 |
Genetic and epigenetic regulation of cancer coagulome – lessons from heterogeneity of cancer cell populations
|
Tawil, Nadim
|
|
|
191 |
S1 |
p. S99-S105
|
artikel
|
| 13 |
Hemostatic biomarkers in occult cancer and cancer risk prediction
|
Marchetti, Marina
|
|
|
191 |
S1 |
p. S37-S42
|
artikel
|
| 14 |
Impact of specific preclinical variables on coagulation biomarkers in cancer-associated thrombosis
|
Selby, Rita
|
|
|
191 |
S1 |
p. S26-S30
|
artikel
|
| 15 |
Inpatient prophylaxis in cancer patients: where is the evidence?
|
Patell, Rushad
|
|
|
191 |
S1 |
p. S85-S90
|
artikel
|
| 16 |
Latest advances in preventing thromboembolic disease in the ambulatory oncology patient
|
Maraveyas, Anthony
|
|
|
191 |
S1 |
p. S91-S98
|
artikel
|
| 17 |
Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer
|
Gerotziafas, Grigoris T.
|
|
|
191 |
S1 |
p. S50-S57
|
artikel
|
| 18 |
Preface to the Proceedings of the 10th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2020
|
Falanga, Anna
|
|
|
191 |
S1 |
p. S1-S2
|
artikel
|
| 19 |
Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future
|
Moik, Florian
|
|
|
191 |
S1 |
p. S3-S11
|
artikel
|
| 20 |
Screening for occult cancer: where are we in 2020?
|
Marín-Romero, Samira
|
|
|
191 |
S1 |
p. S12-S16
|
artikel
|
| 21 |
The thrombin–inflammation axis in cancer progression
|
Cantrell, Rachel
|
|
|
191 |
S1 |
p. S117-S122
|
artikel
|
| 22 |
Thrombosis in hematological malignancies: mechanisms and implications
|
Horowitz, Netanel A.
|
|
|
191 |
S1 |
p. S58-S62
|
artikel
|
| 23 |
Title page
|
|
|
|
191 |
S1 |
p. iii
|
artikel
|
| 24 |
Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life
|
Verso, Melina
|
|
|
191 |
S1 |
p. S123-S127
|
artikel
|
| 25 |
Venous thromboembolism in palliative care patients: what do we know?
|
Noble, Simon
|
|
|
191 |
S1 |
p. S128-S132
|
artikel
|
Tijdschrift beschrijving